Genmab | Marktkapitalisierung



Market Capitalization Veränderung Datum
Agios Pharmaceuticals USD 2B 66M 2025-08
Almirall EUR 2.29B 195.31M 2025-06
Amgen USD 154.93B 4.8B 2025-08
argenx SE EUR 34.69B 6B 2025-08
AstraZeneca GBP 169.84B 45.67B 2025-08
Bayer EUR 25.19B 108.07M 2025-08
BioMarin Pharmaceutical USD 10.92B 378M 2025-08
Demant DKK 55.49B 993.54M 2025-08
Exelixis USD 10.64B 1.94B 2025-08
Fresenius Medical Care EUR 12.17B 2.1B 2025-08
Galapagos EUR 1.86B 291.92M 2025-08
Genmab DKK 87.78B 6.9B 2025-08
GlaxoSmithKline GBP 57.33B 1.09B 2025-08
GN Store Nord DKK 17.52B 2.8B 2025-08
GRIFOLS EUR 5.4B 928.14M 2025-08
Hikma Pharmaceutical GBP 4.42B 226.35M 2024-12
Insmed USD 16.76B 2.34B 2025-08
Merck EUR 46.98B 847.82M 2025-08
Novartis CHF 189.79B 66.39B 2025-08
Regeneron Pharmaceuticals USD 62.39B 6.52B 2025-08
Sanofi EUR 101.06B 998.99M 2025-08
UCB EUR 37.38B 10.41B 2024-12


Genmab Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.